Aviva PLC decreased its stake in shares of PetMed Express, Inc. (NASDAQ:PETS – Get Rating) by 31.9% during the 4th quarter, Holdings Channel reports. The institutional investor owned 52,844 shares of the company’s stock after selling 24,796 shares during the period. Aviva PLC’s holdings in PetMed Express were worth $935,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Captrust Financial Advisors increased its stake in shares of PetMed Express by 72.5% during the first quarter. Captrust Financial Advisors now owns 1,570 shares of the company’s stock valued at $41,000 after acquiring an additional 660 shares during the period. Quantbot Technologies LP increased its position in shares of PetMed Express by 455.7% during the 2nd quarter. Quantbot Technologies LP now owns 2,206 shares of the company’s stock valued at $43,000 after purchasing an additional 1,809 shares during the period. Point72 Hong Kong Ltd raised its stake in shares of PetMed Express by 2,023.8% in the 2nd quarter. Point72 Hong Kong Ltd now owns 3,122 shares of the company’s stock worth $62,000 after buying an additional 2,975 shares in the last quarter. US Bancorp DE lifted its holdings in shares of PetMed Express by 319.1% in the first quarter. US Bancorp DE now owns 3,751 shares of the company’s stock valued at $97,000 after buying an additional 2,856 shares during the period. Finally, Mutual of America Capital Management LLC boosted its stake in PetMed Express by 18.6% during the third quarter. Mutual of America Capital Management LLC now owns 4,181 shares of the company’s stock valued at $82,000 after buying an additional 657 shares in the last quarter. 77.74% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
Several equities analysts have recently issued reports on PETS shares. StockNews.com began coverage on shares of PetMed Express in a research note on Thursday. They issued a “hold” rating on the stock. Morgan Stanley dropped their price target on PetMed Express from $18.00 to $17.00 and set an “underweight” rating on the stock in a report on Thursday, March 23rd.
PetMed Express Stock Down 4.9 %
About PetMed Express
PetMed Express, Inc engages in the provision of markets prescription and non-prescription pet medications, health products and supplies for dogs and cats. Its non-prescription medications include flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies.
- Get a free copy of the StockNews.com research report on PetMed Express (PETS)
- MarketBeat Week in Review – 5/15 – 5/19
- Applied Materials: Cracks In The Chip Recovery Or Time To Buy?
- Deere & Company Rallies On Farm Equipment Boom, Bullish Outlook
- How Many Roth IRAs Can You Have?
- Why You Should Consider Buying Nvidia Ahead Of Earnings
Want to see what other hedge funds are holding PETS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for PetMed Express, Inc. (NASDAQ:PETS – Get Rating).
Receive News & Ratings for PetMed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetMed Express and related companies with MarketBeat.com's FREE daily email newsletter.